2-[4-[(3S)-3-methylpyrrolidin-1-yl]-6-oxo-3-propan-2-ylpyridazin-1-yl]-N-([1,2,4]triazolo[4,3-a]pyridin-6-yl)acetamide

C20H25N7O2 — CID 164914345

IUPAC2-[4-[(3S)-3-methylpyrrolidin-1-yl]-6-oxo-3-propan-2-ylpyridazin-1-yl]-N-([1,2,4]triazolo[4,3-a]pyridin-6-yl)acetamide
SMILESCC(C)c1nn(CC(=O)Nc2ccc3nncn3c2)c(=O)cc1N1CC[C@H](C)C1
InChIInChI=1S/C20H25N7O2/c1-13(2)20-16(25-7-6-14(3)9-25)8-19(29)27(24-20)11-18(28)22-15-4-5-17-23-21-12-26(17)10-15/h4-5,8,10,12-14H,6-7,9,11H2,1-3H3,(H,22,28)/t14-/m0/s1
InChIKeyYVZAOMPTMZSWIQ-AWEZNQCLSA-N
MW395.47 g/mol
LogP1.89
Rot. Bonds5

About 2-[4-[(3S)-3-methylpyrrolidin-1-yl]-6-oxo-3-propan-2-ylpyridazin-1-yl]-N-([1,2,4]triazolo[4,3-a]pyridin-6-yl)acetamide

2-[4-[(3S)-3-methylpyrrolidin-1-yl]-6-oxo-3-propan-2-ylpyridazin-1-yl]-N-([1,2,4]triazolo[4,3-a]pyridin-6-yl)acetamide (PubChem CID 164914345) has the molecular formula C20H25N7O2 and a molecular weight of 395.47 g/mol. Its IUPAC name is 2-[4-[(3S)-3-methylpyrrolidin-1-yl]-6-oxo-3-propan-2-ylpyridazin-1-yl]-N-([1,2,4]triazolo[4,3-a]pyridin-6-yl)acetamide.

Molecular Properties

Compound Name2-[4-[(3S)-3-methylpyrrolidin-1-yl]-6-oxo-3-propan-2-ylpyridazin-1-yl]-N-([1,2,4]triazolo[4,3-a]pyridin-6-yl)acetamide
PubChem CID164914345
Molecular FormulaC20H25N7O2
Molecular Weight395.47 g/mol
Exact Mass395.21
IUPAC Name2-[4-[(3S)-3-methylpyrrolidin-1-yl]-6-oxo-3-propan-2-ylpyridazin-1-yl]-N-([1,2,4]triazolo[4,3-a]pyridin-6-yl)acetamide
SMILESCC(C)c1nn(CC(=O)Nc2ccc3nncn3c2)c(=O)cc1N1CC[C@H](C)C1
InChIInChI=1S/C20H25N7O2/c1-13(2)20-16(25-7-6-14(3)9-25)8-19(29)27(24-20)11-18(28)22-15-4-5-17-23-21-12-26(17)10-15/h4-5,8,10,12-14H,6-7,9,11H2,1-3H3,(H,22,28)/t14-/m0/s1
InChIKeyYVZAOMPTMZSWIQ-AWEZNQCLSA-N
XLogP1.89
TPSA97.42 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds5
Heavy Atoms29
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500395.47
LogP ≤ 51.89
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Analyze 2-[4-[(3S)-3-methylpyrrolidin-1-yl]-6-oxo-3-propan-2-ylpyridazin-1-yl]-N-([1,2,4]triazolo[4,3-a]pyridin-6-yl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[4-[(3S)-3-methylpyrrolidin-1-yl]-6-oxo-3-propan-2-ylpyridazin-1-yl]-N-([1,2,4]triazolo[4,3-a]pyridin-6-yl)acetamide?
The IUPAC name of 2-[4-[(3S)-3-methylpyrrolidin-1-yl]-6-oxo-3-propan-2-ylpyridazin-1-yl]-N-([1,2,4]triazolo[4,3-a]pyridin-6-yl)acetamide (CID 164914345) is 2-[4-[(3S)-3-methylpyrrolidin-1-yl]-6-oxo-3-propan-2-ylpyridazin-1-yl]-N-([1,2,4]triazolo[4,3-a]pyridin-6-yl)acetamide.
What is the SMILES notation for 2-[4-[(3S)-3-methylpyrrolidin-1-yl]-6-oxo-3-propan-2-ylpyridazin-1-yl]-N-([1,2,4]triazolo[4,3-a]pyridin-6-yl)acetamide?
The canonical SMILES for 2-[4-[(3S)-3-methylpyrrolidin-1-yl]-6-oxo-3-propan-2-ylpyridazin-1-yl]-N-([1,2,4]triazolo[4,3-a]pyridin-6-yl)acetamide is CC(C)c1nn(CC(=O)Nc2ccc3nncn3c2)c(=O)cc1N1CC[C@H](C)C1.
What is the InChIKey of 2-[4-[(3S)-3-methylpyrrolidin-1-yl]-6-oxo-3-propan-2-ylpyridazin-1-yl]-N-([1,2,4]triazolo[4,3-a]pyridin-6-yl)acetamide?
The InChIKey is YVZAOMPTMZSWIQ-AWEZNQCLSA-N. The full InChI is InChI=1S/C20H25N7O2/c1-13(2)20-16(25-7-6-14(3)9-25)8-19(29)27(24-20)11-18(28)22-15-4-5-17-23-21-12-26(17)10-15/h4-5,8,10,12-14H,6-7,9,11H2,1-3H3,(H,22,28)/t14-/m0/s1.
What are the key properties of 2-[4-[(3S)-3-methylpyrrolidin-1-yl]-6-oxo-3-propan-2-ylpyridazin-1-yl]-N-([1,2,4]triazolo[4,3-a]pyridin-6-yl)acetamide?
2-[4-[(3S)-3-methylpyrrolidin-1-yl]-6-oxo-3-propan-2-ylpyridazin-1-yl]-N-([1,2,4]triazolo[4,3-a]pyridin-6-yl)acetamide has a molecular weight of 395.47 g/mol, XLogP of 1.89, 5 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[(3S)-3-methylpyrrolidin-1-yl]-6-oxo-3-propan-2-ylpyridazin-1-yl]-N-([1,2,4]triazolo[4,3-a]pyridin-6-yl)acetamide is sourced from PubChem (CID 164914345), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).